Ateroklefit Bio - ke kumu o ka lāʻau
ʻO Atheroclephitis kahi mea palekana e kōkua i ke kaua i ka atherosclerosis e hele ana i ka wā e hoʻopilikiaʻole ai ka lipid metabolism.
Me kēlā mau ʻino, kau ʻia ka kolamu ma nā paia o loko o nā kīʻaha koko i ke ʻano o nā pākī. ʻO ka hopena, ke pilikia nei nā kaʻe i loko o nā moku ʻuʻuku a me ka neʻe ʻana o ke koko.
- ka hopena o ka metabolic o nā kolamu a me nā momona;
- momona;
- maʻi maʻi hypertensive;
- kolamu kiʻekiʻe;
- nā kūlana koʻikoʻi;
- hoʻoikaika kino;
- maʻi mellitus maʻiʻi.
Eia kekahi, hoʻohana kēia mea hana i ka mea pili i ka lāʻau lapaʻau.
Hoʻohui a me ke noi
Loaʻa ka lāʻau lapaʻau i nā pahuhopu, hiki iā 30 a 60 mau ʻāpana paha i pākaʻi, a i ʻole ma nā ʻano o nā wai i pohō i loko o nā pahu he 30, 50 a 100 ml paha.
- ʻiliʻula manu ʻulaʻula;
- ascorbic acid;
- pua; ʻohi aku;
- waikawa: nikotinic, pantothenic, folic;
- kahi maʻamau;
- ʻaʻano protein
- ke silinium me nā ʻāpana ʻē aʻe;
- kekahi mau huameka amino;
- nā vitamina A, B, E, K, D a me nā mea'ē aʻe.
- stearate kalsiuma;
- aerosil;
- cellulose microcrystalline.
ʻO ka hoʻemi ʻana o nā waihona mālama atherosclerotic, ua hoʻoikaikaʻia nā capillaries a me nā moku coronary, kahi e hoʻemi ai i kā lākou permeability a hoʻonui i ka elasticity.
Hoʻomaopopo ʻia e lawe i ka Ateroklefit Bio i ka mālamaʻana i nā maʻi cardiovascular (CVD) i ka hui pū me nā lāʻau ʻē aʻe, me ke hoʻomaʻamaʻa ʻana i ke kino ma ke ʻano holoʻokoʻa.
Pono e hui pū ʻia ka hoʻohana ʻana o kēia meaʻaiʻai me ka nui o ka ʻai ʻana i nā mea kanu a me nā huaʻai, me ka liʻiliʻi ʻana i ka ʻai me ka momona momona. Pono ka palena paʻakai a me nā momona ʻōpala. Eia hoʻi a, eia nō ka ʻōlelo ʻana aku i ka uahi a me ka waiʻona e haʻalele ʻia.
Nā Hoʻohui
ʻAʻohe o Ateroklefit Bio nā hopena hopena, me ka ʻole o ka hopena i kahi hopena maikaʻiʻole i ke kino.
Eia kekahi, ʻaʻohe mea pili i ia, kahi e hiki ai iā ʻoe ke hana i nā hoʻomaha kūpono i nā papa lōʻihi o ka mālama ʻana.
- ʻO ka mālamalama ʻokoʻa o ke kino i kekahi mau lāʻau o ka lāʻau, inā paha i ka ʻulaʻula ʻulaʻula.
- ʻO nā wahine hāpai a hāpai i ka lactating, nā keiki ma lalo o ka makahiki 18, pono e lawe i ka lāʻau lapaʻau me ka mālama nui loa a ma hope iho o ka kūkā ʻana a me ka loea.
- ʻAʻole hiki ke lawe ʻia ka lāʻau lapa inā inā he mau maʻi lōlū, nā waiʻona, maʻi a ʻeha paha ka lolo.
ʻO kēia ma muli o ka hana kiʻekiʻe a me nā loiloi maikaʻi.
ʻO ka lāʻau lapaʻau i hana ʻia e ka mea hana Lūkini ZAO Evalar. ʻO ke kumukūʻai ma Moscow a me St. Petersburg e pili ana iā 290 mau rubles i kēlā me kēia ʻeke (60 mau pūlama) a ma kahi o 200 rubles i pākahi (100 ml).
Ke noiʻi
Ua hana ʻo Altai Medical University i nā noiʻi e hōʻoia i ka hoʻohana ʻana i ka atheroclephitis ma ke ʻano he antiatherosclerotic agent.
ʻO nā mea maʻi me ka palaka cardiovascular i nānā.
- ka huina ʻia i ka hana anti-atherosclerotic a he hana no ka mālama ʻana i nā maʻi naʻau coronary a me hypertension;
- pili ka atheroclephitis i ke kūlana o nā pā o nā kīʻaha koko, ke kiʻekiʻe o ka metabolism cholesterol, ke kūlana o ke kuʻuna o ke koko;
- ke hoʻomanawanui maikaʻi nei ka lāʻau, ʻaʻohe huakino, ʻaʻohe hopena hopena;
- hiki ke hoʻohana 'ia ka lāʻau i nā papa lōʻihi a i ka mālama ʻana paha i ka CVD.
Ke hele nei i nā papa makahiki o ka mālama ʻana me kēia lāʻau kūlohelohe, hiki iā ʻoe ke kōkua maoli i kou kino. A he pono kēia, no ka mea, ʻo ka hopena mau o nā mea kūwaho i waho, ka lawehala ʻana i ka mea ʻai kaulike e alakaʻi nei i nā maʻi. A ʻo ka wahi mua ma waena o lākou he atherosclerosis a me kāna mau hoʻohui. Hiki i ka Ateroclefit Bio ke nāwaliwali a hoʻopau paha i kēia mau hōʻeha, e hoʻolōʻihi iā mākou i ka hauʻoli.
